Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 1:01 AM ET

Healthcare Providers and Services

Company Overview of SK3 Group Inc.

Company Overview

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT International Distributors, Inc. and changed its name to SK3 Group, Inc. in May 2007. SK3 Group, Inc. was founded in 2000 and is headquartered in Los Angeles...

448 S Hill Street

Suite 405

Los Angeles, CA 90013

United States

Founded in 2000

15 Employees

Phone:

305-423-7144

Key Executives for SK3 Group Inc.

SK3 Group Inc. does not have any Key Executives recorded.

SK3 Group Inc. Key Developments

SK3 Group Announces First Sales of Medical Cannabis Product T-Hydrocan(Tm) RMC 40

SK3 Group Inc. announced that the first bottles of its new medicinal cannabis product, T-Hydrocan(TM) RMC 40, will be available from April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The 'RMC' designation indicates 'refined mixed cannabinoids.' T-Hydrocan(TM) RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis. T-Hydrocan(TM) RMC 40 is packaged eight tablets per bottle. The suggested retail price is $35.00 per bottle. T-Hydrocan(TM) RMC 40 was developed by Berkeley Bio-Organic Research Laboratories Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan(TM) product line will be T-Hydrocan(TM) Whole Plant 25 tablets and capsules.

David Hoye Appoints to the Board of Directors of SK3 Group Inc

David Hoye has been appointed to the Board of Directors of SK3 Group Inc. Hoye is co-founder of Berkeley Bio-Organic Research Laboratories, which was acquired in April of 2013.

SK3 Group Develops Cutting Edge Nutritional Supplement 'Alzatrex'

SK3 Group's Berkeley Bio Organic Research Laboratories has developed 'Alzatrex' (TM), an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that 9-THC, the main active ingredient in medical marijuana, decreases -amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain. The combination of a COX-2 inhibitor with medical cannabis also prevents marijuana-induced memory problems and 'brain fog' or 'haze' that is common.

Similar Private Companies By Industry

Company Name Region
Conficare LLC United States
EKLA Corporation United States
Winchester Hospital United States
Healthcare of Today, Inc. United States
Florida Hospital Medical Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 23, 2014
--
Merger/Acquisition
September 29, 2014
SK3 Group, Inc., Substantially all Assets
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SK3 Group Inc., please visit www.medicalgreens.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.